ABIRATERONE STEROIDAL METABOLITES AS BIOMARKERS FOR TREATMENT RESISTANCE IN PROSTATE CANCER

$257,436FY2018Department of the ArmyDOD

The Cleveland Clinic Foundation

Investigators